Egalet's long-acting opioid painkiller Arymo wins FDA approval

(Reuters) – The U.S. Food and Drug Administration said on Monday it has approved Egalet Corp’s long-acting opioid painkiller, Arymo ER. The decision follows the recommendation of an independent panel of advisors to the FDA, which in August voted 18-1 in favor of approval. The FDA did not immediately say whether it has granted the abuse-deterrent label.
Source: Feed3

Leave a Reply

Your email address will not be published. Required fields are marked *